Are Health Care Providers Caring for Pregnant and Postpartum Women Ready to Confront the Perinatal Cannabis Use Challenge?

Abstract

Objective The purpose of this study was to assess health care providers' knowledge and practices related to cannabis use among pregnant and postpartum women.

Study Design A survey of health care providers (n = 75 responders) was conducted across four main regions in the state of Virginia to assess knowledge of adverse health effects associated with perinatal cannabis use, screening tools, follow-up for positive screening, barriers to having discussions about cannabis use, and treatment among pregnant and postpartum women.

Results An astonishing 34.7% of the providers surveyed responded as not being aware of the impacts of cannabis use on the health of the mother and infant, and 66.7% of them reported that they would like some training on feeling comfortable with their knowledge about the impact of perinatal cannabis use on the population they are serving. When asked about providing resources and/or patient education related to cannabis use during pregnancy and/or breastfeeding, 62.7% reported they did not but they would be interested in providing both resources and education. Over one-third of the providers did not have a follow-up process for positive screening. In addition, numerous barriers to asking/screening and/or discussing cannabis use and potential harm reduction methods for the pregnant and postpartum populations emerged such as inadequate or lack of resources for positive screening, lack of knowledge on the topic, unsure about the policies of reporting a positive screening, etc.

Conclusion The findings of this study indicate that health care providers caring for pregnant and postpartum women are not equipped to make appropriate recommendations to patients and guide them through decision-making. Health care providers caring for pregnant and postpartum women need to be knowledgeable on how to best support patients with cannabis use for effective counseling and guidance due to health risks. State policies and resources are needed to ensure training for clinicians on perinatal cannabis.

Key Points

• Providers are not knowledgeable about perinatal cannabis.

• Providers lack resources and do not have a follow-up process.

• Providers would like to receive training on the impact of perinatal cannabis on health outcomes.

Keywords

perinatal cannabis use - pregnancy - postpartum - health care providers

Publication History

Received: 11 October 2023

Accepted: 14 November 2023

Article published online:
13 December 2023

• References

• 1 Volkow ND, Han B, Compton WM, McCance-Katz EF. Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA 2019; 322 (02) 167-169
• 2 Ko JY, Farr SL, Tong VT, Creanga AA, Callaghan WM. Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am J Obstet Gynecol 2015; 213 (02) 201.e1-201.e10
• 3 Bailey BA, Wood DL, Shah D. Impact of pregnancy marijuana use on birth outcomes: results from two matched population-based cohorts. J Perinatol 2020; 40 (10) 1477-1482
• 4 Grzeskowiak LE, Grieger JA, Andraweera P. et al. The deleterious effects of cannabis during pregnancy on neonatal outcomes. Med J Aust 2020; 212 (11) 519-524
• 5 Kharbanda EO, Vazquez-Benitez G, Kunin-Batson A, Nordin JD, Olsen A, Romitti PA. Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy. J Perinatol 2020; 40 (03) 473-480
• 6 Gunn JK, Rosales CB, Center KE. et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016; 6 (04) e009986
• 7 Warshak CR, Regan J, Moore B, Magner K, Kritzer S, Van Hook J. Association between marijuana use and adverse obstetrical and neonatal outcomes. J Perinatol 2015; 35 (12) 991-995
• 8 Hayatbakhsh MR, Flenady VJ, Gibbons KS. et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res 2012; 71 (02) 215-219
• 9 Ko JY, Tong VT, Bombard JM, Hayes DK, Davy J, Perham-Hester KA. Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: a population-based study. Drug Alcohol Depend 2018; 187: 72-78
• 10 Brown RA, Dakkak H, Seabrook JA. Is breast best? Examining the effects of alcohol and cannabis use during lactation. J Neonatal Perinatal Med 2018; 11 (04) 345-356
• 11 Odom GC, Cottler LB, Striley CW, Lopez-Quintero C. Perceived risk of weekly cannabis use, past 30-day cannabis use, and frequency of cannabis use among pregnant women in the United States. Int J Womens Health 2020; 12: 1075-1088
• 12 Jarlenski M, Tarr JA, Holland CL, Farrell D, Chang JC. Pregnant women's access to information about perinatal marijuana use: a qualitative study. Womens Health Issues 2016; 26 (04) 452-459
• 13 Braun IM, Wright A, Peteet J. et al. Medical oncologists' beliefs, practices, and knowledge regarding marijuana used therapeutically: a nationally representative survey study. J Clin Oncol 2018; 36 (19) 1957-1962
• 14 Philpot LM, Ebbert JO, Hurt RT. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam Pract 2019; 20 (01) 17
• 15 Shi Y, Zhu B, Liang D. The associations between prenatal cannabis use disorder and neonatal outcomes. Addiction 2021; 116 (11) 3069-3079
• 16 Weisbeck SJ, Bright KS, Ginn CS, Smith JM, Hayden KA, Ringham C. Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis. Can J Public Health 2021; 112 (01) 49-59
• 17 Carlini BH, Garrett SB, Carter GT. Medicinal cannabis: a survey among health care providers in Washington state. Am J Hosp Palliat Care 2017; 34 (01) 85-91